Woodline Partners’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-535,185
| Closed | -$2.14M | – | 970 |
|
|
2025
Q2 | $2.14M | Sell |
535,185
-468,554
| -47% | -$1.16M | 0.01% | 713 |
|
|
2025
Q1 | $913K | Buy |
1,003,739
+615
| +0.1% | +$852 | 0.01% | 773 |
|
|
2024
Q4 | $2.78M | Hold |
1,003,124
| – | – | 0.02% | 599 |
|
|
2024
Q3 | $5.25M | Buy |
1,003,124
+2,451
| +0.2% | +$12.7K | 0.04% | 384 |
|
|
2024
Q2 | $4.46M | Buy |
1,000,673
+112,606
| +13% | +$546K | 0.04% | 352 |
|
|
2024
Q1 | $6.8M | Buy |
888,067
+588,067
| +196% | +$3.23M | 0.06% | 328 |
|
|
2023
Q4 | $1.28M | Buy |
+300,000
| New | +$1.07M | 0.01% | 397 |
|
|
2023
Q3 | – | Sell |
-288,827
| Closed | -$1.61M | – | 667 |
|
|
2023
Q2 | $1.61M | Buy |
+288,827
| New | +$1.71M | 0.02% | 455 |
|